Significant industry movements include Sage Therapeutics planning layoffs of most staff following acquisition by Supernus Pharmaceuticals, underscoring volatility in neuropharma. Imagene AI raised $23 million in Series B funding, advancing multi-modal digital pathology models for precision medicine. Catalio Capital closed a $400 million fund aimed at opportunistic biotech investments and new company launches. Additional regulatory and financing news from global companies signal an active mid-year period in biopharma and med-tech sectors.